Mental health and HIV/AIDS are closely interlinked. Mentaldisorders, including substance-use disorders, are associated withincreased risk of HIV infection and affect adherence to andefficacy of antiretroviral treatments. Conversely, HIVinfection can increase risk for neuropsychiatric complicationsincluding stress, mood, and neurocognitive disorders. This book provides clinicians with a comprehensive evidenced-basedand practical approach to the management of patients with HIVinfection and co-morbid mental disorders. It provides up-to-dateand clear overviews of current clinical issues, as well as therelevant basic science. Information and data from studies ofdifferent HIV groups (eg men who have sex with men) make the textrelevant to a broad spectrum of clinicians, including those workingwith low socioeconomic status groups in high income countries andthose working in the developing world. The book uses the popular format of the World PsychiatricAssociation’s Evidence and Experience series. Reviewchapters summarize the evidence on the epidemiology, pathogenesisand clinical aspects of mental disorders in HIV,and interventions(both psychotherapy and psychopharmacology including drug-druginteractions). These are complemented by commentariesaddressing particular facets of each topic and providing insightgained from clinical experience. Psychiatrists, psychologists and all mental health staff workingwith HIV-infected patients will find this book of greatbenefit.
This comprehensive text focuses on psychiatric issues associated with HIV/AIDS and provides clinicians with a basic understanding of epidemiology, virology, transmission, and medical treatments inclusive of occupational exposures. Psychosocial, spiritual, and sociocultural aspects of HIV/AIDS are covered, describing implications of HIV/AIDS across minority groups. The treatment section allows clinicians to organize an effective psychiatric treatment plan for all mental disorders associated with HIV/AIDS. Issues of adherence, prevention, and public well-being are emphasized throughout. The management of medical problems such as delirium, dementia, and pain management in special HIV/AIDS patients with co-morbid substance abuse as well as end of life care is also included.
This book focuses on how to formulate a mental health response with respect to the unique elements of pandemic outbreaks. Unlike other disaster psychiatry books that isolate aspects of an emergency, this book unifies the clinical aspects of disaster and psychosomatic psychiatry with infectious disease responses at the various levels, making it an excellent resource for tackling each stage of a crisis quickly and thoroughly. The book begins by contextualizing the issues with a historical and infectious disease overview of pandemics ranging from the Spanish flu of 1918, the HIV epidemic, Ebola, Zika, and many other outbreaks. The text acknowledges the new infectious disease challenges presented by climate changes and considers how to implement systems to prepare for these issues from an infection and social psyche perspective. The text then delves into the mental health aspects of these crises, including community and cultural responses, emotional epidemiology, and mental health concerns in the aftermath of a disaster. Finally, the text considers medical responses to situation-specific trauma, including quarantine and isolation-associated trauma, the mental health aspects of immunization and vaccination, survivor mental health, and support for healthcare personnel, thereby providing guidance for some of the most alarming trends facing the medical community. Written by experts in the field, Psychiatry of Pandemics is an excellent resource for infectious disease specialists, psychiatrists, psychologists, immunologists, hospitalists, public health officials, nurses, and medical professionals who may work patients in an infectious disease outbreak.
The human immunodeficiency virus (HIV) commonly enters the central nervous system, disturbs brain function, and ultimately results in serious brain damage. The most dangerous manifestation of this infection of the brain is HIV-associated dementia, which includes extreme memory loss, slowness in thinking, disorientation, and social incapacity. Most persons who are HIV-infected do not develop severe dementia; however, perhaps 50% of those with AIDS and a smaller proportion of HIV-infected carriers suffer from more subtle brain disorders that can be revealed by proper neuropsychological testing. This ground-breaking volume is the first to summarize the current state of knowledge about the neurocognitive disorders associated with HIV-1 infection. With contributions from leading authorities in the field, the book fully discusses the prevalence, qualitative features, natural course, and effects of neuropsychological impairments in persons with HIV infection. Neuropsychological data are related to findings from studies of brain imaging, neuropathology, and the effects of antiretroviral treatments. This critical work will be essential for neuropsychologists, infectious disease physicians, neurologists, and all those involved in AIDS research and treatment.
|Author||: World Health Organization|
|Release Date||: 1990|
|Pages||: 50 pages|
Current data and trends in morbidity and mortality for the sub-Saharan Region as presented in this new edition reflect the heavy toll that HIV/AIDS has had on health indicators, leading to either a stalling or reversal of the gains made, not just for communicable disorders, but for cancers, as well as mental and neurological disorders.
|Author||: American Psychiatric Association|
|Publisher||: American Psychiatric Publishing|
|Release Date||: 2002|
|ISBN 10||: 9780890423202|
|Pages||: 914 pages|
Developed by the APA to assist in clinical decision making, the "Practice Guidelines" series has become an invaluable resource to help benchmark care strategies for 11 common mental disorders. The APA makes "Practice Guidelines" available to help improve patient care and give members access to the latest information and research. Intended as a professional resource and not a "standard of care," the "Practice Guidelines" provide convenient summaries of what we know about key mental disorders and the effectiveness of specific treatments. The eleven "Practice Guidelines" are: Alzheimer's Disease and Other Dementias Of Late Life Bipolar Disorder, Second Edition Borderline Personality Disorder Delirium Eating Disorders, Second Edition HIV/AIDS Major Depressive Disorder, Second Edition Panic Disorder Psychiatric Evaluation Of Adults Schizophrenia Substance Use Disorder: Alcohol, Cocaine, Opioids These guidelines help you: Understand clinical features and symptoms Make a confident differential diagnosis Evaluate interventions commonly used to treat specific disorders Select the appropriate site of service Educate the patient and family Assess the efficacy and risks of available medications Develop an individualized treatment plan
The WHO Regional Office for Europe has combined its 13 protocols on treatment of and care for people with HIV and AIDS in one volume. The protocols are the cornerstone of the strategic actions that WHO has taken as part of its contribution to achieving the goal of universal access to HIV/AIDS prevention, treatment, care and support services. The protocols were specifically developed for the entire WHO European Region. Together, they represent a comprehensive and evidence-based tool that offers health professionals clear and specific advice on diagnosing and managing a wide range of health issues related to HIV/AIDS for adults, adolescents and children, including antiretroviral treatment, the management of opportunistic infections, tuberculosis, hepatitis, injecting drug use, sexual and reproductive health, the prevention of mother-to-child HIV transmission, immunization, palliative care and post-exposure prophylaxis. [Ed.]
|Author||: David Musyimi Ndetei|
|Release Date||: 2006|
|Pages||: 602 pages|
This book on NeuroAIDS, a collection of chapters written by experts and specialists from around the world, provides a global perspective on HIV and NeuroAIDS in the field, clinic, and laboratory. The chapters address the comorbidity of HIV and other infectious agents, including Zika virus, Ebola, Chagas disease, TB and HCV. Also discussed are key topics, such as: · Molecular socioepidemiology · Global HIV and NeuroAIDS · Neuropathology · cART and blood-brain barrier penetration · HIV replicative oscillations · HIV and SIV evolution · Psychiatric comorbidities · Neurosyphilis · The examination of current and innovative models of translational research to translational effectiveness
During the past two decades, the world scientific community has witnessed major achievements in our understanding of the pathogenesis of HIV infection of the nervous system and HIV-Associated Dementia (HAD). Despite these giant gains, nervous system involvement during AIDS remains a relentlessly progressive disease with a deadly fate in many cases. This book on NeuroAIDS provides a unique resource for both general neurologists as well as basic neuroscientists with profound interests for research on NeuroAIDS. This book has special emphasis on the mechanisms of disease development and progression of HIV-infected patients with NeuroAIDS. The contributors have provided the readers with comprehensive reviews on clinical manifestations of HAD, mechanisms of HIV entry into the central nervous system, the role of cytokines and chemokines in pathogenesis of NeuroAIDS, drug abuse and NeuroAIDS, virus load in HAD, allostasis in HIV and AIDS, stroke in AIDS patients, and neuroimaging of HIV infection of the central nervous system. In addition, there are chapters on Varicella Zoster virus infection of HIV-seropositive and AIDS patients, as well as the molecular basis for opioids and AIDS virus interactions.
|Author||: Institute of Medicine,Board on Global Health,Committee on Nervous System Disorders in Developing Countries|
|Publisher||: National Academies Press|
|Release Date||: 2001-01-01|
|ISBN 10||: 9780309170932|
|Pages||: 458 pages|
Brain disordersâ€"neurological, psychiatric, and developmentalâ€"now affect at least 250 million people in the developing world, and this number is expected to rise as life expectancy increases. Yet public and private health systems in developing countries have paid relatively little attention to brain disorders. The negative attitudes, prejudice, and stigma that often surround many of these disorders have contributed to this neglect. Lacking proper diagnosis and treatment, millions of individual lives are lost to disability and death. Such conditions exact both personal and economic costs on families, communities, and nations. The report describes the causes and risk factors associated with brain disorders. It focuses on six representative brain disorders that are prevalent in developing countries: developmental disabilities, epilepsy, schizophrenia, bipolar disorder, depression, and stroke. The report makes detailed recommendations of ways to reduce the toll exacted by these six disorders. In broader strokes, the report also proposes six major strategies toward reducing the overall burden of brain disorders in the developing world.